The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration.

Journal of Natural Products
Yang LiuYu-Dong Zhou

Abstract

The transcription factor hypoxia-inducible factor-1 (HIF-1) represents an important molecular target for anticancer drug discovery. In a T47D cell-based reporter assay, the Caulerpa spp. algal pigment caulerpin (1) inhibited hypoxia-induced as well as 1,10-phenanthroline-induced HIF-1 activation. The angiogenic factor vascular endothelial growth factor (VEGF) is regulated by HIF-1. Caulerpin (10 microM) suppressed hypoxic induction of secreted VEGF protein and the ability of hypoxic T47D cell-conditioned media to promote tumor angiogenesis in vitro. Under hypoxic conditions, 1 (10 microM) blocked the induction of HIF-1alpha protein, the oxygen-regulated subunit that controls HIF-1 activity. Reactive oxygen species produced by mitochondrial complex III are believed to act as a signal of cellular hypoxia that leads to HIF-1alpha protein induction and activation. Further mechanistic studies revealed that 1 inhibits mitochondrial respiration at electron transport chain (ETC) complex I (NADH-ubiquinone oxidoreductase). Under hypoxic conditions, it is proposed that 1 may disrupt mitochondrial ROS-regulated HIF-1 activation and HIF-1 downstream target gene expression by inhibiting the transport or delivery of electrons to complex III.

References

Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Jan 1, 1970·Journal of the Chemical Society. Perkin Transactions 1·G Aguilar-Santos
Jan 20, 1995·The Journal of Biological Chemistry·G L Wang, G L Semenza
May 23, 2000·Nature·G HelmlingerR K Jain
Oct 3, 2000·Phytochemistry·M B Govenkar, S Wahidulla
Oct 13, 2001·Science·R K Bruick, S L McKnight
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Sep 19, 2002·The Journal of Biological Chemistry·Julie St-PierreMartin D Brand
May 23, 2003·Oncogene·Annika UnruhRoland H Wenger
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Jun 22, 2005·Biochemical and Biophysical Research Communications·Chowdhury Faiz HossainYu-Dong Zhou
Aug 16, 2005·Cancer Cell·Benjamin J MoellerMark W Dewhirst
Mar 28, 2006·Bioorganic & Medicinal Chemistry Letters·Shui-Chun MaoXu Shen
Aug 10, 2006·Biotechnology Journal·Eduardo VotteroMichel Roberge
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leiming LiYu Shen
Oct 21, 2006·Annual Review of Medicine·Napoleone FerraraRobert Kim
Nov 9, 2006·Advances in Experimental Medicine and Biology·M Celeste Simon
Nov 30, 2006·Phytotherapy Research : PTR·Fabíola Dutra RochaValéria Laneuville Teixeira
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rob A CairnsNicholas C Denko
Nov 1, 2008·Molecular Cancer Therapeutics·Lee M GreenbergerHenrik Ørum

❮ Previous
Next ❯

Citations

Nov 28, 2013·Cancer & Metabolism·Claudia CalabreseAnna Maria Porcelli
May 15, 2013·Marine Drugs·Luiz Henrique Agra Cavalcante-SilvaMagna Suzana Alexandre-Moreira
Feb 7, 2012·European Journal of Medicinal Chemistry·Yan XiaKyeong Lee
Dec 12, 2012·Journal of Cellular Biochemistry·Yongzhi YangBinghua Jiao
Apr 20, 2016·Biochemical and Biophysical Research Communications·Alessandra FerramoscaAntonio Terlizzi
Dec 18, 2018·Natural Product Reports·Florence LefrancDavid Newman
Oct 4, 2017·Mini Reviews in Medicinal Chemistry·Jignesh LunagariyaShihai Xu
Jan 14, 2011·Immunopharmacology and Immunotoxicology·V Prabhu, C Guruvayoorappan
Apr 14, 2019·Molecular Biology Reports·Richa MehraSandeep Singh
Dec 15, 2010·Natural Product Reports·John W BluntMichèle R Prinsep
Dec 7, 2016·International Journal of Oncology·Hua YuBinbin Xu
Jun 24, 2017·Frontiers in Oncology·Félix A UrraCésar Cárdenas
Oct 31, 2018·Marine Drugs·Djenisa H A RochaDiana C G A Pinto
Aug 22, 2018·Frontiers in Pharmacology·Celso AlvesRui Pedrosa
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sandipan DattaJames M Angelastro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.